-+ 0.00%
-+ 0.00%
-+ 0.00%

*Supernus and Indivior Say Deal Combines Businesses, With Diversified Portfolio of CNS Medicines Totaling About $2.2B/Combined Annual Rev

Dow Jones·08/03/2026 10:33:00

Please log in to view news